Haemonetics (HAE) news
Recent news
Haemonetics Corp: Barrington Research raises target price to $118 from $95
AInvest Wire · Aug 19, 2026Haemonetics Corp: BTIG raises target price to $110 from $96
BTIG has revised its price target for Haemonetics Corp (NYSE: HAE), raising it to $110 from the previous $96, according to recent reports. The adjustment follows strong performance metrics from the company, which have prompted the firm to maintain a positive outlook on its future prospects. The…
AInvest Wire · Aug 18, 2026Haemonetics Corp - supply agreement is non-exclusive with no minimum purchase commitments - SEC filing
Haemonetics Corporation (NYSE: HAE) has disclosed in a recent SEC filing that its supply agreement with GVS is non-exclusive and does not include minimum purchase commitments. This arrangement follows the company’s 2020 agreement to sell its manufacturing operations in Fajardo, Puerto Rico, to GVS.…
AInvest Wire · Aug 18, 2026Haemonetics to update CSL pact impact in Nov 2026
AInvest Wire · Aug 18, 2026Haemonetics not updating previously issued fiscal 2027 guidance
Haemonetics Corporation (NYSE: HAE) has announced that it is not updating its previously issued fiscal 2027 guidance at this time, according to information available on its Investor Relations website . The company released its first-quarter fiscal 2027 financial results for the period ending June…
AInvest Wire · Aug 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.